发明授权
- 专利标题： Quinolinone compounds as 5-HT4 receptor agonists
- 专利标题（中）： 喹啉酮化合物作为5-HT4受体激动剂
-
申请号： US12234906申请日： 2008-09-22
-
公开(公告)号： US07875629B2公开(公告)日： 2011-01-25
- 发明人: Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
- 申请人： Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
- 申请人地址： US CA South San Francisco
- 专利权人： Theravance, Inc.
- 当前专利权人： Theravance, Inc.
- 当前专利权人地址： US CA South San Francisco
- 代理商 Jeffrey A. Hagenah; Roberta P. Saxon
- 主分类号： A61K31/46
- IPC分类号： A61K31/46
摘要：
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
公开/授权文献
- US20090036483A1 QUINOLINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS 公开/授权日：2009-02-05
信息查询
